142 related articles for article (PubMed ID: 33241484)
21. Differential expression of Oct4 variants and pseudogenes in normal urothelium and urothelial cancer.
Wezel F; Pearson J; Kirkwood LA; Southgate J
Am J Pathol; 2013 Oct; 183(4):1128-1136. PubMed ID: 23933063
[TBL] [Abstract][Full Text] [Related]
22. OCT4B1, a novel spliced variant of OCT4, generates a stable truncated protein with a potential role in stress response.
Farashahi Yazd E; Rafiee MR; Soleimani M; Tavallaei M; Salmani MK; Mowla SJ
Cancer Lett; 2011 Oct; 309(2):170-5. PubMed ID: 21684074
[TBL] [Abstract][Full Text] [Related]
23. Revisiting OCT4 expression in peripheral blood mononuclear cells.
Kotoula V; Papamichos SI; Lambropoulos AF
Stem Cells; 2008 Jan; 26(1):290-1. PubMed ID: 17932416
[TBL] [Abstract][Full Text] [Related]
24. Distinctive expression pattern of OCT4 variants in different types of breast cancer.
Soheili S; Asadi MH; Farsinejad A
Cancer Biomark; 2017; 18(1):69-76. PubMed ID: 27814277
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of OCT4A and SPP1C transcript variant co-expression in early-stage lung adenocarcinoma.
Koshimune S; Kosaka M; Mizuno N; Yamamoto H; Miyamoto T; Ebisui K; Toyooka S; Ohtsuka A
BMC Cancer; 2020 Jun; 20(1):521. PubMed ID: 32503462
[TBL] [Abstract][Full Text] [Related]
26. OCT4B Isoform Promotes Anchorage-Independent Growth of Glioblastoma Cells.
Choi SH; Kim JK; Jeon HY; Eun K; Kim H
Mol Cells; 2019 Feb; 42(2):135-142. PubMed ID: 30622231
[TBL] [Abstract][Full Text] [Related]
27. Induced overexpression of OCT4A in human embryonic stem cells increases cloning efficiency.
Tsai SC; Chang DF; Hong CM; Xia P; Senadheera D; Trump L; Mishra S; Lutzko C
Am J Physiol Cell Physiol; 2014 Jun; 306(12):C1108-18. PubMed ID: 24627557
[TBL] [Abstract][Full Text] [Related]
28. Expression and differentiation between OCT4A and its Pseudogenes in human ESCs and differentiated adult somatic cells.
Jez M; Ambady S; Kashpur O; Grella A; Malcuit C; Vilner L; Rozman P; Dominko T
PLoS One; 2014; 9(2):e89546. PubMed ID: 24586860
[TBL] [Abstract][Full Text] [Related]
29. Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours.
Rijlaarsdam MA; van Herk HA; Gillis AJ; Stoop H; Jenster G; Martens J; van Leenders GJ; Dinjens W; Hoogland AM; Timmermans M; Looijenga LH
Br J Cancer; 2011 Sep; 105(6):854-63. PubMed ID: 21847120
[TBL] [Abstract][Full Text] [Related]
30. Cellular context- and protein level-dependent interaction of pluripotency factor OCT4A with multiple octamer motifs of the same target gene.
Zhou N; Zhang XB; Chen C; Chen XY; Kang B; He JQ; Gong GZ; Wang YJ; Zhou YW
Life Sci; 2020 May; 248():117461. PubMed ID: 32097665
[TBL] [Abstract][Full Text] [Related]
31. Spatiotemporal dynamics of OCT4 protein localization during preimplantation development in mice.
Fukuda A; Mitani A; Miyashita T; Kobayashi H; Umezawa A; Akutsu H
Reproduction; 2016 Nov; 152(5):417-30. PubMed ID: 27495230
[TBL] [Abstract][Full Text] [Related]
32. lncRNA PSORS1C3 is regulated by glucocorticoids and fine-tunes OCT4 expression in non-pluripotent cells.
Mirzadeh Azad F; Malakootian M; Mowla SJ
Sci Rep; 2019 Jun; 9(1):8370. PubMed ID: 31182783
[TBL] [Abstract][Full Text] [Related]
33. Role of Oct4 in maintaining and regaining stem cell pluripotency.
Shi G; Jin Y
Stem Cell Res Ther; 2010 Dec; 1(5):39. PubMed ID: 21156086
[TBL] [Abstract][Full Text] [Related]
34. Alternative translation of OCT4 by an internal ribosome entry site and its novel function in stress response.
Wang X; Zhao Y; Xiao Z; Chen B; Wei Z; Wang B; Zhang J; Han J; Gao Y; Li L; Zhao H; Zhao W; Lin H; Dai J
Stem Cells; 2009 Jun; 27(6):1265-75. PubMed ID: 19489092
[TBL] [Abstract][Full Text] [Related]
35. The miR-134 attenuates the expression of transcription factor FOXM1 during pluripotent NT2/D1 embryonal carcinoma cell differentiation.
Chen Y; Meng L; Yu Q; Dong D; Tan G; Huang X; Tan Y
Exp Cell Res; 2015 Jan; 330(2):442-450. PubMed ID: 25447206
[TBL] [Abstract][Full Text] [Related]
36. Two novel splice variants of SOX2OT, SOX2OT-S1, and SOX2OT-S2 are coupregulated with SOX2 and OCT4 in esophageal squamous cell carcinoma.
Shahryari A; Rafiee MR; Fouani Y; Oliae NA; Samaei NM; Shafiee M; Semnani S; Vasei M; Mowla SJ
Stem Cells; 2014 Jan; 32(1):126-34. PubMed ID: 24105929
[TBL] [Abstract][Full Text] [Related]
37. OCT4 spliced variant OCT4B1 is expressed in human colorectal cancer.
Gazouli M; Roubelakis MG; Theodoropoulos GE; Papailiou J; Vaiopoulou A; Pappa KI; Nikiteas N; Anagnou NP
Mol Carcinog; 2012 Feb; 51(2):165-73. PubMed ID: 21480394
[TBL] [Abstract][Full Text] [Related]
38. Analysis of Human Stem Cell Transcription Factors.
Sneha S; Nagare RP; Manasa P; Vasudevan S; Shabna A; Ganesan TS
Cell Reprogram; 2019 Aug; 21(4):171-180. PubMed ID: 31298562
[TBL] [Abstract][Full Text] [Related]
39. Roles of OCT4 in tumorigenesis, cancer therapy resistance and prognosis.
Villodre ES; Kipper FC; Pereira MB; Lenz G
Cancer Treat Rev; 2016 Dec; 51():1-9. PubMed ID: 27788386
[TBL] [Abstract][Full Text] [Related]
40. DNA methylation of the Oct4A enhancers in embryonal carcinoma cells after etoposide treatment is associated with alternative splicing and altered pluripotency in reversibly senescent cells.
Baryshev M; Inashkina I; Salmina K; Huna A; Jackson TR; Erenpreisa J
Cell Cycle; 2018; 17(3):362-366. PubMed ID: 29372665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
